Welcome to our dedicated page for SITIME SEC filings (Ticker: SITM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SiTime Corporation filings document the public-company record for a Nasdaq-listed semiconductor issuer focused on Precision Timing and silicon timing systems solutions. The company’s 8-K reports furnish operating and financial results, material-event disclosures, material agreements, facility commitments, governance changes, and capital-structure information tied to its common stock.
SiTime’s proxy materials cover board composition, director elections, committee assignments, executive compensation, equity awards, shareholder voting matters, and related governance disclosures. Its regulatory filings also provide formal context for risk, corporate obligations, and transaction-related disclosures while maintaining the company’s operating identity as a fabless provider of MEMS programmable timing solutions.
SiTime (Nasdaq: SITM) filed an 8-K disclosing a firmly underwritten public offering of 1,750,000 common shares at $200.00, targeting $350 million in gross proceeds. Underwriters hold a 30-day option for 262,500 additional shares, lifting potential proceeds to $402.5 million. UBS and Stifel lead a six-bank syndicate; closing is set for June 27 2025 under the company’s automatic shelf (S-3 No. 333-277373). Customary indemnities, covenants and termination rights apply, and Cooley LLP issued the legal opinion (Ex. 5.1).
The raise will bolster liquidity and fund corporate purposes but will increase the outstanding share count, creating immediate dilution for existing holders.
SiTime Corporation (NASDAQ: SITM) has filed a prospectus supplement for an underwritten public offering of 1,750,000 shares of common stock at $200.00 per share, compared with the $203.75 last reported sale price on 25 Jun 2025. Gross proceeds are expected to total $350 million, with underwriting discounts and commissions of $7.00 per share ($12.25 million in total), resulting in net proceeds to the company of $337.75 million before expenses.
The company has granted the underwriters a 30-day option to purchase up to an additional 262,500 shares (15% of the base offering), which, if exercised in full, would raise further gross proceeds of up to $52.5 million. The shares are expected to be delivered to investors on or about 27 Jun 2025. UBS Investment Bank and Stifel are acting as joint book-running managers, with Needham & Company, Goldman Sachs & Co. LLC, Raymond James and Roth Capital Partners also participating in the syndicate.
The filing is made under the company’s automatic shelf registration statement on Form S-3 (effective 26 Feb 2024). Sections on Use of Proceeds, Dilution, and Risk Factors are referenced but not detailed in the excerpt, so the specific application of funds and pro-forma capital structure are not disclosed here. Investors should review the full prospectus for additional information, including risk considerations and forward-looking statements.
SiTime (Nasdaq: SITM) filed a 424B5 prospectus supplement announcing an underwritten public offering of $350 million in common stock.
The company intends to issue roughly 1,506,413 shares at an assumed price of $232.34—the last reported sale price on 23 June 2025. Underwriters UBS Investment Bank, Stifel and Needham & Company have a 30-day option to buy up to an additional $52.5 million of shares. Core sections include Risk Factors (S-9), Use of Proceeds (S-13), Dilution (S-14) and Capitalization (S-15). Neither the SEC nor state regulators have yet approved or disapproved the securities.
The prospectus stresses that investing in the shares involves risk and potential dilution; delivery of the shares is expected on or about a closing date to be set in 2025. Investors should review the detailed risk factors and dilution calculations before committing capital.